Brian Joseph Lynch, SVP and General Counsel at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 25,500 shares at $285.74 ($7.2M) on 2023-01-03, disclosed to the SEC on 2023-01-06.
Open-market sale of $7.2M MDGL by SVP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $277.91 | 600 | $167K | 2.3% |
| 2 | $277.91 | 600 | $167K | 2.3% |
| 3 | $279.10 | 400 | $112K | 1.5% |
| 4 | $279.10 | 400 | $112K | 1.5% |
| 5 | $280.66 | 1,800 | $505K | 7.0% |
| 6 | $280.66 | 1,800 |
| $505K |
| 7.0% |
| 7 | $281.97 | 2,656 | $749K | 10.4% |
| 8 | $281.97 | 2,656 | $749K | 10.4% |
| 9 | $282.97 | 2,628 | $744K | 10.3% |
| 10 | $282.97 | 2,628 | $744K | 10.3% |
| 11 | $283.85 | 1,549 | $440K | 6.1% |
| 12 | $283.85 | 1,549 | $440K | 6.1% |
| 13 | $285.15 | 829 | $236K | 3.3% |
| 14 | $285.15 | 829 | $236K | 3.3% |
| 15 | $285.74 | 2,038 | $582K | 8.1% |
| 16 | $285.74 | 2,038 | $582K | 8.1% |
| 17 | $286.62 | 400 | $115K | 1.6% |
| 18 | $287.86 | 100 | $29K | 0.4% |
| Total | $282.84 avg | 25,500 | $7.2M | 100% |
| Filing → |
| MDGL | SELL | 2022-12-28 | $2.3M | — | Filing → |